SEC ASKS PFIZER FOR BEXTRA, CELEBREX DATA

Pfizer Inc. is responding to a request from the Securities and Exchange Commission for information and documents on its Bextra and Celebrex painkillers, the drugmaker said Tuesday in a filing. The SEC made the request in the second quarter, said Pfizer spokeswoman Mariann Caprino. She said the company has no further comment on the request, except that it is cooperating.

The Washington Post (http://www.washingtonpost.com/wp-dyn/content/article/2005/08/09/AR2005080900519.html)